By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Benitec BioPharma 

2375 Garcia Avenue

Mountain View  California  94043  U.S.A.
Phone: 650-564-9850 Fax: 650-564-9851



Company News
Benitec (BLT.AX) Release: Key Pre-Clinical Data On Oculopharyngeal Muscular Dystrophy (OPMD) Published In Nature Communications 4/4/2017 9:06:37 AM
Benitec (BLT.AX) Completes Second Tranche Placement To Nant Capital To Raise A$5.45 Million 3/13/2017 7:48:07 AM
Benitec (BLT.AX) Makes Significant Progress In Ocular Program 2/2/2017 11:07:43 AM
Benitec (BLT.AX) Initiates Development Work On Head And Neck Cancer Programs After Executing Collaboration Agreement With Nant Capital 1/30/2017 7:32:37 AM
Benitec (BLT.AX) Release: Pharma Receives Orphan Drug Designation In The European Union For BB-301, A ddRNAi Therapeutic In Development For The Treatment Of Oculopharyngeal Muscular Dystrophy 1/17/2017 8:24:17 AM
Benitec (BLT.AX) In-Licenses Clinical Program For Head And Neck Cancer From NantWorks 12/27/2016 6:09:32 AM
Benitec (BLT.AX) Releases Pivotal Data In An In Vivo Hepatitis B Model 12/20/2016 9:21:28 AM
Benitec (BLT.AX) Announces Positive Data For Its Hepatitis B Virus Program 12/20/2016 9:02:41 AM
World's Richest Doctor's NantVentures and Benitec (BLT.AX) Ink Cancer-Focused R&D Pact 10/25/2016 5:49:17 AM
Benitec (BLT.AX) Shakes Up C-Suite, Names New CEO and CFO 8/10/2016 6:10:05 AM